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1Shared Quality Data Results in Increased Protamine Use and Reduced
Bleeding Complications After Carotid Endarterectomy in the Vascular
Study Group of New England
Reshma B. Patel,1 Peter Beaulieu,2 Philip P. Goodney,3 Andrew C. Stanley,1
Jack L. Cronenwett,3 David H. Stone,3 Daniel J Bertges1. 1University of
Vermont College of Medicine, Burlington, Vt; 2University of New England
College of Osteopathic Medicine, Biddeford, Me; 3Dartmouth Hitchcock
Medical Center, Lebanon, NH
Introduction and objectives: The study goal was to evaluate whether
protamine usage after carotid endarterectomy (CEA) increased within the
Vascular Study Group of New England (VSGNE) in response to the
VSGNE presentation (April 2009), the Society for Vascular Surgery presen-
tation (June 2009), and Journal of Vascular Surgery publication (March
2010) “Protamine reduces bleeding complications associated with carotid
endarterectomy without increasing the risk of stroke.”
Methods: We reviewed protamine usage during 9882 CEAs excluding
concomitant coronary bypass within the VSGNE from January 2003 to June
2011. Protamine usage was evaluated biannually using statistical process
control charting. Trends in surgeon use before (n 67) and after 2009 (n
113) were categorized as rare, selective, or routine. End points included
postoperative myocardial infarction (POMI), stroke, death, and reoperation
for bleeding.
Results: Protamine was administered during 54% of procedures, in-
creasing from 46% before 2009 to 61% after 2009 (P .001). The increase
in protamine use surpassed the upper control limit of three standard devia-
tions in 2009 coincident with presentation and publication of the VSGNE
study (Fig). Surgeon usage shifted from rare, selective, and routine over time
from 45%, 18%, and 37% to 24%, 35% and 42%, respectively. Reoperation for
bleeding decreased (0.5% vs 1.4%, P  .001) with similar rates of POMI
(1.0% vs 1.2%, P  .52), stroke, or death (1.1% vs 1.1%, P  .796) in
protamine treated vs untreated patients, respectively. Reoperation for bleed-
ing decreased significantly from 1.2% before 2009 to 0.6% after 2009 (P 
.003).
Conclusions: Protamine use increased by VSGNE surgeons coincident
with presentation of VSGNE-derived data showing the benefit of protamine.
Improvements in the process of care can be achieved in regional quality
groups by sharing safety and efficacy data.
Timing of Perioperative Events Following Carotid Endarterectomy:
In-Hospital vs Post-Discharge Adverse Events
Margriet Fokkema,1 Rodney P. Bensley,1 Ruby C. Lo,1 Allan D. Hamdan,1
Mark C. Wyers,1 Gert Jan de Borst,2 Frans L. Moll,2 Marc L. Schermer-
horn1. 1Beth Israel Deaconess Medical Center, Boston, Mass; 2University
Medical Center Utrecht, Utrecht, The Netherlands
Introduction and objectives: Most studies based on state and nation-
wide registries evaluating perioperative outcome after carotid endarterec-
tomy (CEA) rely on hospital discharge data. Therefore, true 30-day com-
plication risk after carotid revascularization may be underestimated.
Fig.Methods: We used the National Surgical Quality Improvement Pro-
gram database 2005-2010 to assess the in-hospital and postdischarge rate of
1
f
1476ny stroke and stroke/death at 30 days after CEA and identified predictors
or the timing of these events. Univariate analysis including demographics
nd preoperative variables served as a base (threshold P  .2) for multivari-
ble analysis to identify predictors associated with outcome.
Results: A total of 35,916 patients (asymptomatic and symptomatic;
9% men, median age, 72 years) underwent CEA during 2005 to 2010. The
0-day stroke rate was 1.6% (n 591) and the combined stroke/death rate
as 2.2% (n  792), and 31.2% of strokes (0.5%) and 40.9% of combined
vents (0.9%) took place after hospital discharge (median days to stroke, 8
interquartile range, 11]). Women were more likely to have postdischarge
vents than men (stroke, 38.1% vs 29.0%, P .005; stroke/death, 42.8% vs
0.0%, P  .009). Renal failure was also predictive for postdischarge stroke
odds ratio, 3.16; 95% confidence interval, 1.54-6.47), whereas those un-
ergoing emergency procedures and redo-CEA were more likely to have
n-hospital events.
Conclusions: One in three perioperative strokes and deaths after CEA
re missed when only hospital admission data are analyzed. This emphasizes
he need for reporting and comparing 30-day outcomes. Selected subgroups
t increased risk for either in-hospital or postdischarge events merit further
nvestigation and may benefit from changes in management. Particularly in
oman and those with renal failure, we need to be alert to the ongoing risk
f adverse events after hospital discharge.
he Effect of Postoperative Stroke and Myocardial Infarction on
ong-Term Survival After Carotid Revascularization
essica P. Simons,1 Philip P. Goodney,2 Donald T. Baril,1 Brian W. Nolan,2
athanael D. Hevelone,3 Jack L. Cronenwett,2 Louis M. Messina,1 Andres
chanzer1, Vascular Study Group of New England 1University of Massachu-
etts Medical School, Worcester, Mass; 2Dartmouth-Hitchcock Medical
enter, Lebanon, NH; 3Harvard School of Public Health, Boston, Mass
Introduction and objectives: The largest randomized controlled trial
omparing the efficacy of carotid endarterectomy (CEA) vs carotid artery
tenting (CAS) showed equivalent outcomes for the composite end point of
ostoperative stroke, myocardial infarction (MI), or death. However, CAS
ad a higher risk of postoperative stroke, and CEA had a higher risk of MI.
his analysis of long-term survival after carotid revascularization tested the
ypothesis that postoperative stroke reduced long-term survival more than
ostoperative MI.
Methods: The Vascular Study Group of New England was used to
dentify all CEA and CAS procedures from 2003 to 2011. Patients were
tratified according to whether they experienced a minor or major postop-
rative stroke, MI (troponin elevation, electrocardiographic changes and/or
linical symptoms), or neither. Primary study end points were 1- and 5-year
urvival. Multivariable Cox proportional hazards models compared the
agnitude of effect of stroke and MI on survival.
Results: Of 8315 patients, 81 (1.0%) experienced postoperative MI
nd 63 (0.8%) experienced stroke (37% major, 64% minor). Survival signif-
cantly differed at 1 year: MI, 84%; stroke, 77%, neither, 96% (log-rank, P
0001). After adjusting for confounders, stroke was an independent predic-
or of death at 1 year (hazard ratio [HR], 6.6; 95% confidence interval [CI],
.7-12; P  .0001), as was MI (HR, 3.6; 95% CI, 2-6.8; P  .0001). At 5
ears, on multivariable modeling, stroke was again an independent predictor
f death (HR, 2.7; 95% CI, 1.7-4.3; P .0001), with a magnitude of effect
imilar to that of MI (HR, 2.8; 95% CI, 1.8-4.3; P  .0001).
Conclusions: Postoperative stroke conferred a sixfold increased hazard
f death at 1 year, which was nearly twice that associated with postoperative
I. By 5 years, survival curves converged and the disadvantage conferred by
troke was similar to that by MI. This study demonstrates that stroke
ortends a significantly worse survival prognosis than MI within the first year
fter carotid revascularization.
ace As a Predictor of Morbidity and Mortality After Carotid
ndarterectomy
ilary A. Brown, Michael Sullivan, Richard Gusberg, Alan Dardik, Julie Ann
osa, Jeffrey Indes. Yale University, New Haven, Conn
Introduction and objectives: Racial disparities in the outcomes of
atients undergoing carotid endarterectomy (CEA) have been reported. We
ought to examine the contemporary relationship between race and out-
omes, as well as to report postdischarge events after CEA.
Methods: American College of Surgeons-National Surgical Quality
mprovement Program data were reviewed to identify all CEAs performed
rom 2005 to 2010. The influence of race on outcomes was examined.
ultivariate analysis was performed using variables found to be significant
n bivariate analysis. The primary outcomes were stroke and mortality.
econdary outcomes were other 30-day complications, including postdis-
harge events.
Results: CEA was performed on 29,114 white patients (95.7%) and
316 black patients (4.3%). The overall stroke and mortality rates were
.65% and 0.7%, respectively. The stroke rate was 1.6% for whites and 2.5%
or blacks (P  .0009). The 30-day mortality rate was 0.7% for white
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Volume 56, Number 5 Abstracts 1477patients, and 1.4% for blacks (P .0002). There was a longer operating time
(P  .001) and total length of stay (P  .001), more postoperative
pneumonias (P  .0049), unplanned intubations (P  .001), ventilator
dependence (P  .001), cardiac arrests (P  .001), bleeding requiring
transfusions (P  .0024), and returns to the operating room (P  .0021)
among black patients. Multivariate logistic regression identified black race as an
independent risk factor for 30-day mortality (relative risk, 1.9;P .0007). Black
patients also had more in-hospital deaths than white patients (73.7% vs 43.1%,
P .001). The rate of postdischarge strokes did not differ between the groups:
36.4% of all strokes occurred after discharge at a mean of 8.3 days and 54.3% of
deaths occurred after discharge at a mean of 11 days.
Conclusions: Black race is identified as an independent risk factor for
30-day mortality after CEA. A significant proportion of strokes and deaths
occur after discharge in both racial groups evaluated.
Progression of Asymptomatic Carotid Stenosis Despite Optimal Med-
ical Therapy
Valy Boulom, Mark Conrad, Shankha Mukhopadhyay, Virendra Patel, Ashu
Garg, Karen Furie, Richard Cambria. Massachusetts General Hospital,
Boston, Mass
Introduction and objectives: Despite level 1 evidence in support of
carotid endarterectomy (CEA) vs medical therapy in selected asymptomatic
patients, an alternative posture is that optimal medical therapy (OMT) has
not been adequately studied and that such OMT has reduced stroke risk to
levels wherein CEA is no longer justified. The goal of this study was to
determine the natural history of patients with asymptomatic moderate
(50%-69%) carotid stenosis (AMCS) in a contemporary cohort as a function
of their associated medical therapy.
Methods: Patients with AMCS determined by duplex ultrasound
(DUS) imaging from 2005 to 2006 were identified in our hospital database.
Patients were included in the cohort if they had at least one additional DUS
during the 6-year follow-up interval. Patient characteristics, including med-
ication history and lipid levels, were collected. Patients were considered to
have OMT if they were on aspirin and a statin with a low-density lipoprotein
(LDL) level100 mg/dL. Study end points included progression of carotid
disease by DUS (70%-100%), development of ipsilateral neurologic symp-
toms (stroke/transient ischemic attack), and death.
Results: There were 906 carotids in 801 patients in the study cohort.
The average age was 72.5 years, 77.3% had hypertension, 59.7% had
coronary artery disease (CAD), and 84% were on a statin. The LDL choles-
terol level was always normal (100) in 56.4%, and 29.4% had OMT. The
5-year actuarial outcomes are detailed in the Table. Ipsilateral symptoms
developed in 97 patients during follow-up (58% of these were strokes).
Multivariate predictors of disease progression were chronic kidney disease
(hazard ratio [HR], 2.14; confidence interval [CI], 1.22-3.76; P  .0008),
and statin use (HR, 1.59; CI, 1.0-2.53; P .0049). The multivariate models
of symptom development and survival showed that statin use was protective
for both (symptoms: HR, .046; CI, .026-0.79; P  .0005; survival: HR,
.050; CI, .034-0.73; P  .00004).
Conclusions: OMT failed to prevent disease progression or develop-
ment of ipsilateral symptoms in patients with AMCS.
Table. Five-year outcomes
Variable
Cohort, %
(n  906)
OMT, %
P
Yes
(n  266)
No
(n  640)
Survival 75.4 75.4 75.4 .86
Freedom from disease
progression 61.5 60.6 61.7 .37
Freedom from symptoms 87 85 87.9 .17
Freedom from ipsilateral
CEA/CAS 71.7 67.5 73.6 .10
Outcomes of Endovascular Interventions for Salvage of Renal Trans-
plant Allografts
Shipra Arya, Dawn M. Coleman, Nicholas Osborne, Peter K. Henke, John
E. Rectenwald, Michael Englesbe, Katherine A. Gallagher. University of
Michigan, Ann Arbor, Mich
Introduction and objectives: As renal transplantation has been per-
formed with increased frequency, interventions to preserve graft function and
integrity have been steadily increasing. This study examines the outcomes of
endovascular therapy based on indication for renal allograft salvage.
Methods: A prospective transplant registry was queried for all patients
undergoing endovascular interventions for transplant allograft salvage from
2002 to 2011. Demographics, perioperative data, and transplant function
outcomes were extracted and analyzed.
n
mResults: Among 34 renal transplant recipients who underwent endo-
ascular interventions for graft salvage, the mean age was 48.2 years (18-74
ears), and 62% were men. The indications for intervention included wors-
ning serum creatinine (n  15), renovascular hypertension (n  11), and
tructural abnormalities identified on noninvasive imaging (n 8). Translu-
inal angioplasty, with or without stenting, was done in 26 patients: 14
41.2%) with significant transplant stenosis, 11 (32.4%) with peripheral
rterial disease (PAD) in proximal iliac vessels, and one with iliac dissection.
ive arteriovenous fistulae and two pseudoaneurysms required emboliza-
ion. One patient had deep venous thrombosis causing obstruction of
llograft outflow requiring lysis. There were no periprocedural deaths, and
0-day morbidity was 17.6%. Of patients with worsening renal function,
7% had improvement or stabilization of their renal function. Interestingly,
nly 36% of patients with renovascular hypertension showed improvement.
ean follow-up was 4.2 years. There were no significant differences in
ransplant allograft survival over the duration of follow-up based on indica-
ion for endovascular intervention (Fig; log-rank test, P  .03).
Conclusions: Endovascular salvage of renal allograft transplants can be
afely done for various indications, although patients with renovascular
ypertension were less likely to improve. Despite differences in symptomatic
utcome, the indication for initial intervention does not significantly influ-
nce the long-term transplant graft survival.
linical Effectiveness of Secondary Interventions for Restenosis Fol-
owing Renal Artery Angioplasty and Stenting: Does it Help, Hurt or
ven Make a Difference?
enjamin S. Brooke, Samuel T. Simone, Philip P. Goodney, Randall R.
eMartino, Daniel B. Walsh, David H. Stone, Richard J. Powell, Jack L.
ronenwett, Brian W. Nolan. Dartmouth-Hitchcock Medical Center, Leb-
non, NH
Introduction and objectives: Secondary interventions for restenosis
fter renal artery angioplasty and stenting are commonly performed, despite
imited data on their effectiveness. This study was designed to evaluate
hether successful outcomes are achieved in patients after endovascular
reatment of recurrent renal artery stenosis (RAS).
Methods: We conducted a retrospective review of all patients who
nderwent renal artery angioplasty or stenting, or both, for renovascular
ypertension between 2001 and 2011 at Dartmouth-Hitchcock Medical
enter. We compared the clinical effectiveness of secondary vs primary
nterventions. Nonparametric models were used to identify factors associ-
ted with successful outcomes, as measured by changes in blood pressure,
stimated glomerular filtration rate (eGFR), and number of antihypertensive
edications.
Results: Thirty-nine patients (54 renal arteries) underwent secondary
nterventions for recurrent RAS, and 180 patients (180 arteries) underwent
rimary intervention. There were no significant differences between patients
ndergoing primary vs secondary interventions with respect to preoperative
edication usage (including antihypertensive, antiplatelet or statin medica-
ions), comorbid conditions, or blood pressure. Primary and secondary
nterventions were both completed using a similar proportion of bare-metal
tents (90%), with no difference in procedural complications or technical
uccess. At a mean follow-up of 23 months (range, 1-128 months), similar
mprovements in renal function were found between patients undergoing
rimary and secondary interventions (Fig). There were no differences in
Fig.umber of antihypertensive medications, overall blood pressure manage-
ent, or overall survival.
